Jeff Kagan Expands Column Distribution and Industry Partnerships
Jeff Kagan is an industry analyst and columnist in wireless, 5G, AI, and telecom innovation.
Atlanta, GA (FreePR.org) -- Industry Analyst and Columnist Jeff Kagan, recognized as a leading voice in the wireless, 5G, AI, telecom, and technology sectors, is announcing new growth opportunities for news websites and client companies to broaden their market influence by partnering.
With a prolific career spanning decades, Kagan has written thousands of columns for top news platforms and appeared as a guest expert on major television networks and investor channels. His expertise, insights, and ability to simplify complex industry trends have made him a trusted resource for media, business executives, investors, and customers alike.
Kagan is now expanding his reach in two vital ways:
1. Publishing his columns on new news sites. This will benefit them by attracting new readership.
2. Assisting client companies in wireless, telecom, AI, and technology sectors to grow their visibility and reach in a competitive marketplace.
“The communications and technology landscape is constantly evolving. My goal is to help news sites and companies stay ahead of the curve by providing expert analysis and increased visibility,” said Jeff Kagan.
Executives interested in learning how to boost their company’s market presence and editors seeking compelling, expert-driven content are invited to connect with Jeff Kagan for collaboration opportunities.
Dick Martin, former EVP of Public Relations at AT&T, says, “Jeff Kagan has been described as the most widely quoted analyst in the telecommunications industry”, in his book titled Tough Calls: AT&T and the Hard Lessons Learned from the Telecom Wars.
Contact Information: Jeff Kagan e-mail: jeff@jeffKAGAN.com Website: www.jeffKAGAN.com LinkedIn: https://www.linkedin.com/in/jeff-kagan/ Twitter (X): https://x.com/jeffkagan
Explore a sampling of Jeff Kagan’s work by searching for “Jeff Kagan” on Google under ALL and NEWS.
About Jeff Kagan:
Jeff Kagan is an Atlanta-based Industry Analyst, Columnist, Consultant, Influencer, and Keynote Speaker. For over four decades, he has provided analysis and commentary on innovation, market trends, and company performance in wireless, telecom, 5G, 6G, AI, and other high-growth sectors across both B2B and B2C markets.
###
Sponsor Message
By choosing Canadian pharmacies, millions of Americans gain access to lower-cost medications like Lipitor, Crestor, and Nexium. Diabetes patients depend on insulin like Humalog and Lantus, while asthma and COPD sufferers use Advair Diskus and Ventolin inhalers. Medications such as Zoloft, Prozac, and Abilify help with mental health disorders, while blood thinners like Eliquis, Plavix, and Xarelto provide crucial stroke prevention. Frequently ordered medications include Celebrex for pain and inflammation and Synthroid for thyroid support. Additionally, erectile dysfunction is treated with Viagra and Cialis, and Type 2 diabetes is managed with medications like Januvia. Those dealing with narcolepsy or chronic sleepiness benefit significantly from wakefulness agents like Provigil and Nuvigil. Canadian pharmacies make life-enhancing treatments like Cymbalta for nerve pain and Aricept for Alzheimer's accessible to patients across the U.S.
